RECEPTOR-BINDING PROPERTIES INVITRO AND INVIVO OF RITANSERIN - A VERY POTENT AND LONG-ACTING SEROTONIN-S-2 ANTAGONIST

被引:0
|
作者
LEYSEN, JE
GOMMEREN, W
VANGOMPEL, P
WYNANTS, J
JANSSEN, PFM
LADURON, PM
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:600 / 611
页数:12
相关论文
共 50 条
  • [1] RECEPTOR-BINDING PROPERTIES INVITRO AND INVIVO OF SOME LONG-ACTING OPIATES
    LEYSEN, JE
    LADURON, PM
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1978, 232 (02): : 343 - 346
  • [2] NALOXAZONE, A LONG-ACTING OPIATE ANTAGONIST - EFFECTS ON ANALGESIA IN INTACT ANIMALS AND ON OPIATE RECEPTOR-BINDING INVITRO
    PASTERNAK, GW
    CHILDERS, SR
    SNYDER, SH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1980, 214 (03): : 455 - 462
  • [3] EFFECTS OF RITANSERIN, A NOVEL SEROTONIN-S-2 RECEPTOR ANTAGONIST, ON THE SECRETION OF PITUITARY-HORMONES IN NORMAL HUMANS
    TEPAVCEVIC, D
    GILJEVIC, Z
    KORSIC, M
    HALIMI, S
    SUCHANEK, E
    JELIC, T
    AGANOVIC, I
    KOZIC, B
    PLAVSIC, V
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (01) : 1 - 5
  • [4] A NEW SPECIFIC CCK RECEPTOR ANTAGONIST - VERY POTENT INVITRO AND INVIVO
    NIEDERAU, M
    NIEDERAU, C
    GRENDELL, JH
    WILLIAMS, JA
    STROHMEYER, G
    DIGESTION, 1986, 35 (01) : 43 - 43
  • [5] INVITRO AND INVIVO BINDING CHARACTERISTICS OF A NEW LONG-ACTING HISTAMINE H-1 ANTAGONIST, ASTEMIZOLE
    LADURON, PM
    JANSSEN, PFM
    GOMMEREN, W
    LEYSEN, JE
    MOLECULAR PHARMACOLOGY, 1982, 21 (02) : 294 - 300
  • [6] Binding properties of a potent, long-acting new thromboxane receptor antagonist, [3H]S 18886, on human, rat and dog platelet membrane
    Descombes, JJ
    Menant, Y
    Lavielle, G
    Verbeuren, TJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : U112 - U112
  • [7] PHARMACOLOGICAL PROFILE OF RITANSERIN - A VERY SPECIFIC CENTRAL SEROTONIN S2-ANTAGONIST
    AWOUTERS, F
    NIEMEGEERS, CJE
    MEGENS, AAHP
    MEERT, TF
    JANSSEN, PAJ
    DRUG DEVELOPMENT RESEARCH, 1988, 15 (01) : 61 - 73
  • [8] HOE-140 A NEW POTENT AND LONG-ACTING BRADYKININ-ANTAGONIST - INVIVO STUDIES
    WIRTH, K
    HOCK, FJ
    ALBUS, U
    LINZ, W
    ALPERMANN, HG
    ANAGNOSTOPOULOS, H
    HENKE, S
    BREIPOHL, G
    KONIG, W
    KNOLLE, J
    SCHOLKENS, BA
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (03) : 774 - 777
  • [9] 2 NEW DOPAMINE AGONISTS THAT ARE LONG-ACTING INVIVO BUT SHORT-ACTING INVITRO
    GROSSMAN, A
    YEO, T
    DELITALA, G
    HATHWAY, NR
    BESSER, GM
    CLINICAL ENDOCRINOLOGY, 1980, 13 (06) : 595 - 599
  • [10] A NEW LONG-ACTING H2-RECEPTOR ANTAGONIST
    RICHARDSON, CT
    FELDMAN, M
    FORDTRAN, JS
    GASTROENTEROLOGY, 1980, 78 (05) : 1243 - 1243